Ignite Creation Date:
2025-12-24 @ 6:31 PM
Ignite Modification Date:
2025-12-25 @ 4:01 PM
Study NCT ID:
NCT02325557
Status:
COMPLETED
Last Update Posted:
2024-04-02
First Post:
2014-12-22
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
ADXS31-142 Alone and in Combination With Pembrolizumab (MK-3475) in Participants With Previously Treated Metastatic Castration-Resistant Prostate Cancer (mCRPC)